Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
boston blog main
clinical trials
3
×
life sciences
national blog main
national top stories
3
×
new york blog main
new york top stories
san diego blog main
san diego top stories
3
×
biotech
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
national
novartis
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
akcea therapeutics
akouos
alder biopharmaceuticals
allergan
alnylam pharmaceuticals
amag pharmaceuticals
amgen
amunix
anirvan ghosh
What
medicines
3
×
drug
fda
acquisitions
ago
akcea
alnylam
amgen
amyloidosis
announced
approval
approved
attr
available
battle
bio
candidates
ceo
class
collabs
covid
daniel
deal
debilitating
developed
disease
genetic
gets
gilead
gilead’s
head
help
introduce
ipo
migraine
month
new
nod
oks
o’day
Language
unset
Current search:
medicines
×
photo
×
" san diego top stories "
×
" clinical trials "
×
" national top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
